Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 126 clinical trials
Appropriate Duration of Anti-Platelet and Thrombotic Strategy After 12 Months in Patients With Atrial Fibrillation Treated With Drug Eluting Stents

recommend triple therapy with anticoagulants and double antiplatelet therapy (DAPT) in patients with atrial fibrillation for 1 month after coronary intervention, followed by co-administration of NOAC with

anticoagulation therapy
fibrillation
noac
infarct
stroke
  • 0 views
  • 25 Jan, 2021
  • 1 location
THrombo-Embolic Event in Onco-hematology

patients in our institution shows that almost 40% of patients over 65 years of age take anticoagulant or antiplatelet therapy. In this specific population (i.e., with cancer and hypocoagulability

thromboembolism
venous thrombosis
coagulopathy
platelet aggregation
sample analysis
  • 0 views
  • 25 Jan, 2021
  • 1 location
Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial

This trial is comparing medical approaches for stroke prevention in people who have atrial fibrillation (AF) and have undergone a successful procedure called ablation to eliminate or substantially reduce the arrhythmia. AF is normally associated with an increased risk of stroke which in many patients can be prevented with appropriate …

electrocardiogram
atrial fibrillation
anticoagulation therapy
fibrillation
stroke
  • 200 views
  • 21 Mar, 2021
  • 59 locations
Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Patients After Intracerebral Hemorrhage

Intracerebral hemorrhage (ICH) in patients with non-valvular atrial fibrillation (NVAF) poses a particular dilemma for thromboprophylaxis. Left atrial appendage occlusion (LAAO) is a non-pharmacological approach to prevent cardiac embolism in NVAF. The risk-benefit ratio of LAAO in patients with NVAF after ICH is unknown. The aim of STROKECLOSE is to …

left atrial appendage occlusion
anticoagulation therapy
atrial fibrillation
noac
stroke
  • 0 views
  • 21 Jan, 2021
  • 2 locations
Intensive Rhythm Monitoring to Decrease Ischemic Stroke and Systemic Embolism - the Find-AF 2 Study

Patients who have suffered a stroke are having an increased risk of having recurrent stroke in the future. This risk of stroke is increased by atrial fibrillation, which often "comes and goes" (called paroxysmal) and hence escapes routine diagnostics. The hypothesis of Find-AF 2 is that enhanced (evaluation in a …

holter monitor
electrocardiogram
anticoagulation therapy
atrial fibrillation
fibrillation
  • 0 views
  • 25 Jan, 2021
  • 7 locations
Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II

The primary objective of this trial is to assess the effects of ticagrelor plus aspirin versus clopidogrel plus aspirin on reducing the 3-month risk of any stroke (both ischemic and hemorrhagic, primary outcome) when initiated within 24 hours of symptom onset in CYP2Y19 LOF alleles carriers with TIA or minor …

clopidogrel
ticagrelor
aspirin
cerebral infarction
ischemic stroke
  • 0 views
  • 11 Mar, 2021
  • 214 locations
FLOW Evaluation to Guide Revascularization in Multi-vessel ST-elevation Myocardial Infarction

Although current guidelines recommend fractional flow reserve (FFR) to identify haemodynamically relevant coronary lesion(s) in stable patients when evidence of ischaemia is not available (Class I, Level of Evidence: A), no published study has assessed the usefulness of FFR to guide percutaneous coronary intervention (PCI) in ST-elevation myocardial infarction (STEMI) …

percutaneous coronary intervention
coronary artery disease
angiography
stenosis
stemi
  • 6 views
  • 23 Jan, 2021
  • 1 location
Clopidogrel Aspirin Therapy (CAT) Versus Apixiban Aspirin Therapy (AAT) After Lower Limb Revascularization

the Aim of the work is to compare the effect of CAT (Clopidogrel aspirin therapy) and AAT (Apixiban aspirin therapy) after lower extremity revascularization. The study will be conducted at the department of vascular surgery in Mansoura university hospitals in a randomized controlled Prospective study over 2 years: 2019-2021. It …

  • 4 views
  • 23 Jan, 2021
  • 1 location
Re-EValuating the Inhibition of Stress Erosions (REVISE) Trial

Patients who are critically ill in the in the Intensive Care Unit (ICU), especially those who need a breathing machine, can develop ulcers in the stomach that bleed. To prevent bleeding, many such patients around the world receive a drug called pantoprazole that decreases acid production. However, today, compared to …

resuscitation
  • 285 views
  • 24 Jan, 2021
  • 36 locations
Functional Assessment in Elderly MI Patients With Multivessel Disease

Elderly patients presenting with myocardial infarction (MI) and multivessel disease are the highest risk population with the worst prognosis. No trial has ever been designed to optimize their outcome. The actual real-life standard of care is, in the best of the cases, culprit only revascularization. However, real-life registries show that …

stenosis
biodegradable polymer
revascularisation
stroke
infarct
  • 0 views
  • 23 Jan, 2021
  • 30 locations